If you wait for lagging outcomes, such as readmissions, it may be months before you realize if the initiative is working or not, explained Susan Mani, MD, vice president of Clinical Transformation and Ambulatory Quality at LifeBridge Health.
If you wait for lagging outcomes, such as readmissions, it may be months before you realize if the initiative is working or not, explained Susan Mani, MD, vice president of Clinical Transformation and Ambulatory Quality at LifeBridge Health.
Transcript
Why is it important to not just look at endgame outcomes but also process outcomes when determining the value of initiatives addressing social determinants of health?
That is critical to success. If you wait and look for what I call a lagging outcome, like readmissions, you may go months before realizing the initiative of programs you have in place really are not moving the needle. What we had to do operationally was break it down into specific behaviors, which led to some process measures our team could follow. If we know that we had issues around access, then how well are we doing with our access? Is every patient getting a follow-up appointment within the specified time period, and not only are they getting they appointment on discharge, are they actually getting to that appointment? That really tells us if we’re getting successful with our measures. Same thing when we were talking about transportation. Which of our patients really had an assessment done to see whether they had transportation issues, and did we actually supply them with their transportation needs?
Medication is another perfect example. So, in all of those, it really led down to what are the specific behaviors that our physicians needed to do, and how well are we doing it, what are the specific things our care management teams needed to do and our nurses needed to do, and also for our patients and their families, they’re very integral to their own care plan; so, how well are we doing at engaging our patients and their families? By looking at those things month to month, we know well ahead of the time of our readmissions how well we are going to do.
Public Hospitals More Likely to Extend Unprofitable Services After 340B Participation, Study Finds
May 10th 2024Public hospitals were significantly more likely to sustain access to unprofitable services following 340B Drug Pricing Program participation, while nonprofit hospitals were mostly unaffected, according to a recent study.
Read More
CMS Medicare Final Rule: Advancing Benefits, Competition, and Consumer Protection
May 7th 2024On this episode of Managed Care Cast, we're talking with Karen Iapoce, senior director of government products and programs at ZeOmega, about the recent CMS final rule on Medicare Part D and Medicare Advantage.
Listen
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Posters Characterize DMD Caregiver Experiences, Impact of Gene Therapy on Caregiving Demands
May 10th 2024Posters presented at the ISPOR—The Professional Society for Health Economics and Outcomes Research meeting explored Duchenne muscular dystrophy (DMD) caregiver experiences and gene therapy’s impact on work opportunities for caregivers.
Read More
A Focus on Women: AUA Best Posters Highlight Female Athletes, Prenatal Care, and Women in Urology
May 9th 2024Three posters from the American Urological Association (AUA) 2024 Annual Meeting focused on urinary incontinence in female athletes, prenatal care for fetuses with spina bifida in California, and the experiences of women residents at the Brady Urological Institute.
Read More